©2025 Stanford Medicine
Trigger Point Injections Versus Lidocaine Patch for Myofascial Pain in the Emergency Department
Not Recruiting
Trial ID: NCT05151510
Purpose
The aim of this trial is to investigate the efficacy of trigger point injections with 1% lidocaine in reducing myofascial back and neck pain in the Emergency Department compared to lidocaine patches 5%.
Official Title
A Randomized Controlled Study Comparing Trigger Point Injections With 1% Lidocaine Versus 5% Lidocaine Patch for Myofascial Pain in the Emergency Department
Stanford Investigator(s)
Jon B. Lee, MD
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine Clinical Assistant Professor, Emergency Medicine
Eligibility
Inclusion Criteria:
* 18 years or older
* Diagnosed with myofascial pain of the posterior neck or back. \*The diagnosis of myofascial pain was based on established criteria of having a palpable taut band (trigger point) that when depressed reproduced the patient's pain.
Exclusion Criteria:
* midline spinal tenderness
* evidence of radiculopathy
* pregnant
* have an allergy to lidocaine
* altered or deemed incapable of making informed consent
* had signs of infection or skin breakdown over the trigger point.
Intervention(s):
procedure: Trigger point injection with 1% lidocaine
drug: Lidocaine patch 5%
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305